Researchers are using nanoparticles to target drugs at specific cells, like cancer, avoiding the harmful side effects these treatments have on the rest of the body.
Category: Mothers and Babies
Evidence for community-based breastfeeding support
HMRI and University of Newcastle Mothers and Babies researchers have just completed a breastfeeding study to determine the impact of lactation support.
Prevent Prem study to assess premature birth risk
HMRI is part of a world-first study called Prevent Prem that aims to develop a tool to predict who is at risk of preterm birth and put interventions into place early.
Helicopter retrieval project in Nepal attracts $146.4M in World Bank funding
An innovative helicopter retrieval project that was pioneered at HMRI by Distinguished Laureate Professor Roger Smith and former HMRI PHD student, Dr Binod Sharma, has just received a funding injection of $146.4M.
New video explains why stillbirth is not the mother’s fault
Researchers and artists from the Hunter Medical Research Institute (HMRI) and the University of Newcastle have collaborated to create a tool to help women who have experienced stillbirth.
Hello! Hello! Meet Michael and Ollie – the first babies born into the NEW1000
On 15 July 2021, weighing in at just 900gms and one kilogram, twin boys Michael and Ollie North became the first babies to be born into the NEW1000 family study.
A new study answers vital question about preterm labour and opens the door for future treatments
A team of researchers from the Hunter Medical Research Institute (HMRI) and the University of Newcastle has discovered the process of labour during preterm birth is different from that of full-term birth. In a paper recently published in the prestigious American Journal of Obstetrics and Gynecology, the research team discovered a distinct difference in the […]
HMRI researcher awarded a fellowship to fight preterm birth using nanoparticles
Dr Jonathan Paul from the HMRI Mothers and Babies research group has been awarded an Early-Mid Career Fellowship from NSW Health to continue his work to prevent preterm birth.
Tackling health issues at their origin with NEW1000 study
Researchers will study the human microbiome in pregnant women, fathers, and their children to determine the impact of a healthy microbiome on health outcomes.
Giving existing drugs a second chance
Preventing the early onset of labour is vital in the fight against pre-term birth but unfortunately developing new drugs is a long and difficult process. Fortunately, there are already several well-studied existing drugs that are known to prevent early labour or stop labour once it has begun.
